Category: Press Releases
April 19, 2024
Balchem Announces Conference Call for First Quarter 2024 Financial Results
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review 1st Quarter 2024 financial results.
February 16, 2024
Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Ted Harris, Chairman, CEO, and President of Balchem said, "Our full year 2023 results highlight the resilience of our business model in a challenging and volatile market environment."
February 2, 2024
Balchem Announces Conference Call for Fourth Quarter 2023 Financial Results
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review 4th Quarter 2023 financial results.
July 28, 2023
Balchem Announces Second Quarter 2023 Financial Results
Ted Harris, Chairman, President, and CEO of Balchem said, “We delivered solid second quarter financials, and I am particularly pleased with our strong profitability and margin performance as we move forward from the highly inflationary period we experienced over the last two years.”
February 10, 2023
Balchem Announces Conference Call for Fourth Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 24th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2022 results.
October 21, 2022
Balchem Announces Conference Call for Third Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, November 4th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2022 results.
August 30, 2022
Balchem Corporation Acquires Bergstrom Nutrition
Balchem Corporation is excited to announce the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.
July 15, 2022
Balchem Announces Conference Call for Second Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 29th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2022 results.
June 21, 2022
Balchem Corporation Completes Acquisition of Kappa Bioscience AS
We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
June 14, 2022
Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS
Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
April 22, 2022
Balchem Releases 2021 Sustainability Report
Balchem Corporation today released its 2021 Sustainability Report, which captures the Company's commitment to managing our Environmental, Social and Governance (ESG) performance.
April 15, 2022
Balchem Announces Conference Call for First Quarter 2022 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review 1st Quarter 2022 results.